Emerging mitotic inhibitors for non-small cell carcinoma.
about
Nanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein traffickingNanoparticle delivery of an AKT/PDK1 inhibitor improves the therapeutic effect in pancreatic cancer.Cell cycle inhibitors for the treatment of NSCLC.Tubulin inhibitors in non-small cell lung cancer: looking back and forward.Co-delivery of Sildenafil (Viagra(®)) and Crizotinib for synergistic and improved anti-tumoral therapy.
P2860
Emerging mitotic inhibitors for non-small cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Emerging mitotic inhibitors for non-small cell carcinoma.
@en
type
label
Emerging mitotic inhibitors for non-small cell carcinoma.
@en
prefLabel
Emerging mitotic inhibitors for non-small cell carcinoma.
@en
P2093
P2860
P1476
Emerging mitotic inhibitors for non-small cell carcinoma.
@en
P2093
Assunta Sgambato
Francesca Casaluce
Paolo Maione
P2860
P304
P356
10.1517/14728214.2013.777426
P407
P577
2013-03-01T00:00:00Z